These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16838605)
21. Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Ng VW; Koh M; Tan SY; Tan PH Am J Clin Pathol; 2007 Feb; 127(2):248-53. PubMed ID: 17210521 [TBL] [Abstract][Full Text] [Related]
22. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression. Warrick JI; Humphrey PA Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726 [TBL] [Abstract][Full Text] [Related]
23. Performance comparison of anti-p504s (SP116) Rabbit Monoclonal Primary Antibody vs. Monoclonal Rabbit Anti-Human AMACR clone 13H4 when duplexed with VENTANA Basal Cell Cocktail (34βE12+p63) as a diagnostic aid for prostatic adenocarcinoma using immunohistochemistry. Lindner V; Waydelich A; Chen CC; Jones C; Stratton SP Virchows Arch; 2021 Aug; 479(2):337-343. PubMed ID: 33811532 [TBL] [Abstract][Full Text] [Related]
24. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Parsons JK; Gage WR; Nelson WG; De Marzo AM Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556 [TBL] [Abstract][Full Text] [Related]
25. [Alpha-methylacyl-CoA racemase: a useful marker for diagnosis of prostatic carcinoma]. Jiang Z; Ma K; Wu CL; Yang XJ Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):401-3. PubMed ID: 15498205 [No Abstract] [Full Text] [Related]
26. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases. Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803 [TBL] [Abstract][Full Text] [Related]
27. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis. Yang XJ; Tretiakova MS; Sengupta E; Gong C; Jiang Z Hum Pathol; 2003 May; 34(5):462-70. PubMed ID: 12792920 [TBL] [Abstract][Full Text] [Related]
28. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Skinnider BF; Oliva E; Young RH; Amin MB Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Herawi M; Epstein JI Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076 [TBL] [Abstract][Full Text] [Related]
30. [Value of new prostate cancer markers: alpha methylacyl CoA racemase (P504S) and p63]. Molinié V; Hervé JM; Lugagne PM; Yonneau L; Ellard S; Lebret T; Botto H Prog Urol; 2005 Sep; 15(4):611-5. PubMed ID: 16459672 [TBL] [Abstract][Full Text] [Related]
31. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer. Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043 [TBL] [Abstract][Full Text] [Related]
32. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells. Zhou M; Shah R; Shen R; Rubin MA Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893 [TBL] [Abstract][Full Text] [Related]
33. The significance of the P504S expression pattern of high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens. Helpap B Virchows Arch; 2006 Apr; 448(4):480-4. PubMed ID: 16506014 [TBL] [Abstract][Full Text] [Related]
34. Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase. Scarpelli M; Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R Int J Immunopathol Pharmacol; 2012; 25(1):67-74. PubMed ID: 22507319 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of routine application of P504S, 34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens. Pavlakis K; Stravodimos K; Kapetanakis T; Gregorakis A; Athanassiadou S; Tzaida O; Constantinides C Int Urol Nephrol; 2010 Jun; 42(2):325-30. PubMed ID: 19655267 [TBL] [Abstract][Full Text] [Related]
36. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Zhou M; Aydin H; Kanane H; Epstein JI Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314 [TBL] [Abstract][Full Text] [Related]
37. [Detection of P504S (alpha-methylacyl-CoA racemase) in prostatic adenocarcinomas]. Xiao Y; Chen J; Luo YF; Cao JL; Ling Q; Jin F Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1362-6. PubMed ID: 15387946 [TBL] [Abstract][Full Text] [Related]